Clinical Trials in Detroit

Showing 15661-15680 of 19,719 trials

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

NCT02367274

A prospective, non-randomized trial for the extension and replication of the development database of brain electrical activity recordings and clinical information collected from patients who present to the ED following closed head injury.

Brain Injuries

BrainScope Company, Inc.421 participantsStarted Jan 2015

Hartford, Connecticut, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +8 more locations

COMPLETEDPhase 32.6 miles

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

NCT00488631

The purpose of this study is to assess the safety and efficacy of golimumab administered subcutaneously (under the skin) injections in maintenance therapy.

Colitis, Ulcerative

Janssen Research & Development, LLC1,228 participantsStarted Sep 2007

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Anaheim, California, United States +294 more locations

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Find Trials by Condition in Detroit

Canadian Active & Maintenance Modified Pentasa Study

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

The Drug Induced Renal Injury Consortium

Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis

Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

AMG 595 First-in-Human in Recurrent Gliomas

Strategies to Improve Islet Survival

CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia

Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)